Aytu Biopharma (AYTU) Operating Expenses (2010 - 2026)
Aytu Biopharma (AYTU) posted quarterly Operating Expenses of $11.7 million for Q1 2026, up 12.31% year-over-year from $10.4 million in Q1 2025, and up 0.6% quarter-over-quarter from $11.6 million in Q4 2025.
Aytu Biopharma (AYTU) Operating Expenses (2010 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has reported Operating Expenses for 17 consecutive years, with $11.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 12.31% year-over-year to $11.7 million; the TTM figure through Mar 2026 stood at $51.8 million (up 5.53% YoY), while the FY2025 annual figure was $53.7 million, up 5.95% from the prior year.
- Operating Expenses improved to $11.7 million in Q1 2026 per AYTU's latest filing, from $11.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $66.1 million in Q1 2022 and bottomed at $10.4 million in Q1 2025.
- Historically, Operating Expenses has averaged $18.8 million across 5 years, with a median of $13.3 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 2179.55% — and 2023, when it plunged 67.78%.
- Aytu Biopharma's Operating Expenses stood at $24.2 million in 2022, then tumbled by 52.58% to $11.5 million in 2023, then climbed by 8.94% to $12.5 million in 2024, then fell by 7.11% to $11.6 million in 2025, then grew by 0.6% to $11.7 million in 2026.
- Business Quant data shows AYTU's Operating Expenses at $11.7 million in Q1 2026, $11.6 million in Q4 2025, and $10.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Aytu Biopharma | 24.86 Mn | -1.86 Mn | 7.60 Mn | 11.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.66 Mn |
| Dec 31, 2025 | 11.59 Mn |
| Sep 30, 2025 | 10.69 Mn |
| Jun 30, 2025 | 17.88 Mn |
| Mar 31, 2025 | 10.39 Mn |
| Dec 31, 2024 | 12.48 Mn |
| Sep 30, 2024 | 12.92 Mn |
| Jun 30, 2024 | 13.33 Mn |
| Mar 31, 2024 | 11.96 Mn |
| Dec 31, 2023 | 11.46 Mn |
| Sep 30, 2023 | 13.91 Mn |
| Jun 30, 2023 | 18.40 Mn |
| Mar 31, 2023 | 21.30 Mn |
| Dec 31, 2022 | 24.16 Mn |
| Sep 30, 2022 | 19.84 Mn |
| Jun 30, 2022 | 31.78 Mn |
| Mar 31, 2022 | 66.11 Mn |
| Dec 31, 2021 | 23.59 Mn |
| Sep 30, 2021 | 40.16 Mn |
| Jun 30, 2021 | 35.37 Mn |